Neusignal Therapeutics is a pioneering biotechnology company based in Tokyo, Japan, focused on the development of innovative therapies for Alzheimer’s disease
Neusignal Therapeutics is a pioneering biotechnology company based in Tokyo, Japan, focused on the development of innovative therapies for Alzheimer’s disease. The company is dedicated to advancing novel drug candidates aimed at slowing the progression of Alzheimer’s, a condition that is rapidly increasing worldwide.